指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

实施药师用药安全建议与高风险美国老年人医疗资源利用减少和死亡率降低相关

Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans.
指南 / 共识 · J Am Pharm Assoc (2003) · 2022-08-30
一句话结论在强化药物治疗管理模式下,实施药师用药安全审查建议的Part D受益人医疗总费用、住院、急诊就诊和死亡率均低于未参与审查者。

该回顾性前后队列研究评估2018至2019年接受用药安全审查(MSR)的Medicare Part D受益人,将实施至少1条建议者(viMSR组,N=602)与未参与MSR者(FTE组,N=7052)比较2018至2019年各结局变化。viMSR组总Medicare费用每年低2162美元(P=0.020)、Part A费用每年低1855美元(P=0.024)、每100受益人每年住院少9.1次(P=0.020)、急诊就诊少10.8次(P=0.014)、2019年死亡率低3.8%(P<0.001)。作者认为实施药师MSR建议与医疗资源利用和死亡率改善相关。

要点

  • viMSR组较FTE组总Medicare费用每年低2162美元(P=0.020),Part A费用每年低1855美元(P=0.024)。
  • viMSR组每100受益人每年住院少9.1次(P=0.020),急诊就诊少10.8次(P=0.014)。
  • viMSR组2019年死亡率较FTE组低3.8%(P<0.001)。
  • 4384名完成MSR的受益人中仅602人(13.7%)实施了至少1条药师建议。
  • 作者认为实施药师MSR建议与MSR合格受益人医疗资源利用和死亡率改善相关。

适用人群与场景

  • 2018年和2019年被纳入MSR服务的Medicare Part D受益人。
  • viMSR队列:2018年首次接受MSR、2019年再次接受MSR,且2018年MSR中至少1条建议经核实得到实施者(N=602)。
  • FTE队列:2018年和2019年均被纳入MSR服务但截至2019年底未参与MSR者(N=7052)。
  • 死亡率分析放宽2019年连续参保要求,比较各组2019年死亡比例。

研究设计与关键结果

  • 研究类型:回顾性前后队列研究,评估2018年和2019年被纳入MSR服务的Part D受益人。
  • viMSR队列N=602,FTE队列N=7052;4384名完成MSR的受益人中602人(13.7%)实施了至少1条建议。
  • 计算两队列2018至2019年各结局变化并比较组间差异,分析对基线多病情况进行了校正。
  • 总Medicare费用:viMSR组较FTE组每年低2162美元(P=0.020)。
  • Part A Medicare费用:viMSR组较FTE组每年低1855美元(P=0.024)。
  • 住院:viMSR组较FTE组每100受益人每年少9.1次(P=0.020)。
  • 急诊就诊:viMSR组较FTE组每100受益人每年少10.8次(P=0.014)。
  • 死亡率:viMSR组2019年死亡比例较FTE组低3.8%(P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性前后队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在MSR中实施药师建议与MSR合格受益人医疗资源利用和死亡率改善相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: A medication safety review (MSR) is a novel, pharmacist-driven, technology-supported intervention that prioritizes adverse drug event risk mitigation. Previous research has shown that Medicare Part D beneficiaries who received MSRs in an enhanced medication therapy management (EMTM) model realized improvements in total Medicare spending, hospitalizations, emergency department (ED) visits, and mortality compared to control. However, it is unknown whether beneficiaries implemented pharmacists' MSR recommendations.

OBJECTIVE: The objective of the study was to evaluate whether MSR recommendation implementation is associated with improvements in these same outcomes for Part D beneficiaries enrolled in EMTM compared to a control group.

METHODS: This retrospective, pre-post, cohort study evaluated outcomes for beneficiaries who were targeted for MSR services in 2018 and 2019. The "validated implementation MSR (viMSR)" cohort included those who received their first-ever MSR in 2018, received another MSR in 2019, and validated implementation of ≥1 recommendation in their 2018 MSR. The "failed to engage" (FTE) cohort included beneficiaries who were targeted for MSR services in both 2018 and 2019 but did not engage in an MSR at any point through the end of 2019. For both cohorts, we calculated the 2018-to-2019 change for each outcome and then determined whether year-over-year changes differed significantly between cohorts. For mortality, we relaxed the requirement for continuous enrollment in 2019, permitting us to compare the proportion of beneficiaries that died in each group in 2019. Analyses were adjusted for baseline multimorbidity.

RESULTS: Of 4384 beneficiaries who completed MSRs, 602 (13.7%) implemented ≥1 recommendation. The viMSR cohort (N = 602) outperformed the FTE cohort (N = 7052) in total Medicare costs ($2162/y lower; P = 0.020), Part A Medicare costs ($1855/y; P = 0.024), hospitalizations (9.1 fewer admissions/100 beneficiaries/y, P = 0.020), ED visits (10.8 fewer visits/100 beneficiaries/y, P = 0.014), and mortality (3.8% fewer died in 2019; P < 0.001).

CONCLUSION: Implementing pharmacists' recommendations in MSRs was associated with improved health care resource utilization and mortality for MSR-eligible beneficiaries.

来源:J Am Pharm Assoc (2003),查看原文。版权归原作者所有。

参考来源

  1. Bankes DL, Jin H, Williams R, et al. Implementing pharmacists' medication safety recommendations is associated with reduced health care resource utilization and mortality in high-risk older Americans. J Am Pharm Assoc (2003). 2022. PMID: 36167762. doi:10.1016/j.japh.2022.08.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。